European Medicines Agency Recommends Suspension Of Marketing Authorisations For Carisoprodol-containing Medicinal Products
The European Medicines Agency (EMEA) has recommended the suspension of marketing authorisations for all medicinal products containing carisoprodol. Carisoprodol products are available in 12 Member States under prescription, mainly for the treatment of acute lower back pain. [click link for full article]
More: continued here
Filed under: Pain / Anesthetics on November 18th, 2007